An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

NCT06557733 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

38

Enrollment

NIH

Sponsor class

Conditions

Colorectal Carcinoma
Familial Adenomatous Polyposis

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
DRUG: EP2/EP4 Antagonist TPST-1495
PROCEDURE: Esophagogastroduodenoscopy
PROCEDURE: Gastrointestinal Endoscopy
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)